Elsevier Appoints Industry Leader Omry Bigger as President of its Global Clinical Solutions Business Unit

Elsevier 新しいタブ／ウィンドウで開く Health, a global leader in medical information and data analytics, today announced the appointment of Mr. Omry Bigger as President, Clinical Solutions at Elsevier Health. He joins Elsevier from LexisNexis Legal & Professional, another part of RELX, a leading global provider of information-based analytic tools.

Omry brings over 14 years of leadership experience from LexisNexis Legal & Professional, where he served as SVP, Large Markets at LexisNexis North America.

Notably, Omry played a pivotal role in the successful commercial roll-out of Lexis+ AI, the first Generative AI offering across RELX. Under Omry’s leadership, the Clinical Solutions business will aim to further strengthen its portfolio of trusted products supporting clinicians across the world, including the recently launched ClinicalKey AI.

Jan Herzhoff, President of Elsevier Health said: “With his extensive expertise in commercial go-to-market activities, highly competitive markets, and generative AI, Omry is well-equipped to lead Elsevier's Clinical Solutions business toward accelerated growth. His deep understanding of customer needs and his ability to deliver innovative solutions will be invaluable as we continue to enhance our portfolio and drive growth.”

Commenting on his appointment, Omry said: “I am delighted to be joining Elsevier Health at such an exciting time for the business. We are well positioned to take advantage of the many opportunities provided by AI in healthcare, and I look forward in working with the highly skilled and dedicated Clinical Solutions team to deliver exceptional value to customers, and ultimately, to improve patient outcomes.”

About Elsevier Health

For more than 140 years, Elsevier has supported the work of researchers and healthcare professionals by providing current, evidence-based information that can help empower students and clinicians to provide the best healthcare possible. Growing from our roots, Elsevier Health applies innovation, facilitates insights, and helps drive more informed decision-making for our customers across global health. We support health providers by providing accessible, trusted evidence-based information to take on the infodemic; prepare more future health professionals with effective tools and resources; provide insights that help clinicians improve patient outcomes; deliver healthcare that is truly inclusive; and supports a more personalized and localized healthcare experience.

Diversity and inclusion are the foundation of our innovation, and our teams are committed to creating education and practice solutions that reflect the diversity of our world. Elsevier Health is helping lay the groundwork for more equitable healthcare worldwide. We bring the same rigor to our digital information solutions as we do to our publishing, allowing us to offer knowledge and valuable analytics that help our users make breakthroughs and drive progress for the benefit of every patient.

エルゼビアについて エルゼビアは、科学情報と分析を牽引するグローバル企業として、研究者や医療従事者が社会の利益のために科学を進歩させ、医療成果を向上させることを支援しています。我々は信頼できるエビデンスベースのコンテンツと高度なAI対応デジタルテクノロジーに基づくソリューションにより、インサイトと重要な意思決定を促進することでこれを実現しています。

エルゼビアは、140 年以上にわたり研究および医療コミュニティの活動を支援してきました。全世界で 2,500 人以上の技術者を含む 9,500 人の従業員がおり、重要な職務における研究者や、図書館員、アカデミックリーダー、資金提供者、政府機関、R&D 関連企業、医師、看護師、将来の医療従事者や教育者を支援することに従事してきました。2,900 誌以上の科学ジャーナルと代表的な参考文献には、Cell Press、The Lancet、Gray's Anatomy など、各分野の主要なタイトルを含みます。 エルゼビア・ファウンデーション 新しいタブ／ウィンドウで開くと共に、開発途上国および世界中の科学、研究、医療分野におけるインクルージョン＆ダイバーシティを推進するため、支援コミュニティと連携して活動しています。 エルゼビアは、プロフェッショナルおよびビジネス顧客向けの情報に基づく分析および意思決定ツールのグローバルプロバイダーである RELX 新しいタブ／ウィンドウで開くグループの一部です。業務内容やデジタルソリューション、コンテンツ詳細については、 www.elsevier.com/ja-jp 新しいタブ／ウィンドウで開くをご参照ください。